cefepime- cefepime hydrochloride injection, powder, for solution
meitheal pharmaceuticals inc. - cefepime hydrochloride (unii: i8x1o0607p) (cefepime - unii:807pw4vqe3) - cefepime for injection is indicated in the treatment of pneumonia (moderate to severe) caused by susceptible strains of streptococcus pneumoniae , including cases associated with concurrent bacteremia, pseudomonas aeruginosa , klebsiella pneumoniae , or enterobacter species. cefepime for injection as monotherapy is indicated for empiric treatment of febrile neutropenic patients. in patients at high risk for severe infection (including patients with a history of recent bone marrow transplantation, with hypotension at presentation, with an underlying hematologic malignancy, or with severe or prolonged neutropenia), antimicrobial monotherapy may not be appropriate. insufficient data exist to support the efficacy of cefepime monotherapy in such patients [see clinical studies (14.1)] . cefepime for injection is indicated in the treatment of uncomplicated and complicated urinary tract infections (including pyelonephritis) caused by susceptible isolates of escherichia coli or klebsiella pneumoniae , when the infec
cefepime-aft
aft pharmaceuticals ltd - cefepime dihydrochloride monohydrate 1.189 g equivalent to cefepime 1 g - powder for injection - 1 g - active: cefepime dihydrochloride monohydrate 1.189 g equivalent to cefepime 1 g excipient: arginine - adults: cefepime-aft is indicated for the treatment of the indications listed below when caused by susceptible bacteria: · lower respiratory tract infections, including pneumonia and bronchitis · urinary tract infections , both complicated, including pyelonephritis, and uncomplicated infections · skin and skin structure infections · intra-abdominal infections, including peritonitis and biliary tract infections · septicaemia · empiric treatment in febrile neutropenic patients.
cefepime-aft
aft pharmaceuticals ltd - cefepime dihydrochloride monohydrate 2.378 g equivalent to cefepime 2 g - powder for injection - 2 g - active: cefepime dihydrochloride monohydrate 2.378 g equivalent to cefepime 2 g excipient: arginine - adults: cefepime-aft is indicated for the treatment of the indications listed below when caused by susceptible bacteria: · lower respiratory tract infections, including pneumonia and bronchitis · urinary tract infections , both complicated, including pyelonephritis, and uncomplicated infections · skin and skin structure infections · intra-abdominal infections, including peritonitis and biliary tract infections · septicaemia · empiric treatment in febrile neutropenic patients.
cefepime kabi
fresenius kabi new zealand limited - cefepime dihydrochloride monohydrate 1.1892 g equivalent to cefepime 1g - powder for injection - 1 g - active: cefepime dihydrochloride monohydrate 1.1892 g equivalent to cefepime 1g excipient: arginine - adults: cefepime kabi is indicated for the treatment of the indications listed below when caused by susceptible bacteria: · lower respiratory tract infections, including pneumonia and bronchitis · urinary tract infections , both complicated, including pyelonephritis, and uncomplicated infections · skin and skin structure infections · intra-abdominal infections, including peritonitis and biliary tract infections · septicaemia · empiric treatment in febrile neutropenic patients.
cefepime kabi
fresenius kabi new zealand limited - cefepime dihydrochloride monohydrate 2.3785 g equivalent to cefepime 2g - powder for injection - 2 g - active: cefepime dihydrochloride monohydrate 2.3785 g equivalent to cefepime 2g excipient: arginine - adults: cefepime kabi is indicated for the treatment of the indications listed below when caused by susceptible bacteria: · lower respiratory tract infections, including pneumonia and bronchitis · urinary tract infections , both complicated, including pyelonephritis, and uncomplicated infections · skin and skin structure infections · intra-abdominal infections, including peritonitis and biliary tract infections · septicaemia · empiric treatment in febrile neutropenic patients.
apo-cefepime powder for solution
apotex inc - cefepime (cefepime hydrochloride) - powder for solution - 1g - cefepime (cefepime hydrochloride) 1g - fourth generation cephalosporins
apo-cefepime powder for solution
apotex inc - cefepime (cefepime hydrochloride) - powder for solution - 2g - cefepime (cefepime hydrochloride) 2g - fourth generation cephalosporins
dbl cefepime for injection cefepime (as hydrochloride) 2g powder for injection vial
hospira australia pty ltd - cefepime -
dbl cefepime for injection cefepime (as hydrochloride) 2g powder for injection via
hospira australia pty ltd - cefepime -
cefepime noridem 1 g inj./inf. sol. (pwdr.) i.v. vial
noridem enterprises ltd. - cefepime dihydrochloride monohydrate 1189 mg - eq. cefepime 1000 mg - powder for solution for injection/infusion - 1 g - cefepime dihydrochloride monohydrate 1189 mg - cefepime